Ion Beam Applications SA (IBAB.BR)
EUR 13.06
(1.08%)
EUR 13.06
(1.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 41.58 Million EUR | 1.75% |
| 2022 | 40.86 Million EUR | -40.75% |
| 2021 | 68.97 Million EUR | -19.91% |
| 2020 | 86.12 Million EUR | 27.83% |
| 2019 | 67.37 Million EUR | -21.46% |
| 2018 | 85.78 Million EUR | 100.67% |
| 2017 | 42.75 Million EUR | 42.97% |
| 2016 | 29.9 Million EUR | -5.6% |
| 2015 | 31.67 Million EUR | -0.63% |
| 2014 | 31.87 Million EUR | -32.28% |
| 2013 | 47.07 Million EUR | -33.21% |
| 2012 | 70.47 Million EUR | 28.02% |
| 2011 | 55.05 Million EUR | 21.26% |
| 2010 | 45.4 Million EUR | 612.52% |
| 2009 | 6.37 Million EUR | -82.37% |
| 2008 | 36.13 Million EUR | 38.02% |
| 2007 | 26.18 Million EUR | 10.92% |
| 2006 | 23.6 Million EUR | -7.11% |
| 2005 | 25.41 Million EUR | 52.8% |
| 2004 | 16.63 Million EUR | -68.97% |
| 2003 | 53.6 Million EUR | -70.86% |
| 2002 | 183.96 Million EUR | -20.99% |
| 2001 | 232.83 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 32.43 Million EUR | 0.0% |
| 2023 FY | 41.58 Million EUR | 1.75% |
| 2023 Q2 | 41.58 Million EUR | 0.0% |
| 2023 Q4 | 41.58 Million EUR | 0.0% |
| 2022 FY | 40.86 Million EUR | -40.75% |
| 2022 Q2 | 64.74 Million EUR | 0.0% |
| 2022 Q4 | 40.86 Million EUR | 0.0% |
| 2021 Q4 | 68.97 Million EUR | 0.0% |
| 2021 Q2 | 76.77 Million EUR | 0.0% |
| 2021 FY | 68.97 Million EUR | -19.91% |
| 2020 Q4 | 86.12 Million EUR | 0.0% |
| 2020 FY | 86.12 Million EUR | 27.83% |
| 2020 Q2 | 92.15 Million EUR | 0.0% |
| 2019 Q2 | 91.24 Million EUR | 0.0% |
| 2019 FY | 67.37 Million EUR | -21.46% |
| 2019 Q4 | 67.37 Million EUR | 0.0% |
| 2018 Q2 | 75.38 Million EUR | 0.0% |
| 2018 FY | 85.78 Million EUR | 100.67% |
| 2018 Q4 | 85.78 Million EUR | 0.0% |
| 2017 Q4 | 42.75 Million EUR | 0.0% |
| 2017 FY | 42.75 Million EUR | 42.97% |
| 2017 Q2 | 28.79 Million EUR | 0.0% |
| 2016 Q2 | 30.96 Million EUR | 0.0% |
| 2016 FY | 29.9 Million EUR | -5.6% |
| 2016 Q4 | 29.9 Million EUR | 0.0% |
| 2015 FY | 31.67 Million EUR | -0.63% |
| 2015 Q2 | 29.27 Million EUR | 0.0% |
| 2015 Q4 | 31.67 Million EUR | 0.0% |
| 2014 FY | 31.87 Million EUR | -32.28% |
| 2014 Q4 | 31.87 Million EUR | 0.0% |
| 2014 Q2 | 34.47 Million EUR | 0.0% |
| 2013 Q2 | 79.62 Million EUR | 0.0% |
| 2013 Q4 | 47.07 Million EUR | 0.0% |
| 2013 FY | 47.07 Million EUR | -33.21% |
| 2012 Q2 | 74.57 Million EUR | 0.0% |
| 2012 Q4 | 70.47 Million EUR | 0.0% |
| 2012 FY | 70.47 Million EUR | 28.02% |
| 2011 Q4 | 55.05 Million EUR | 0.0% |
| 2011 FY | 55.05 Million EUR | 21.26% |
| 2011 Q2 | 43.01 Million EUR | 0.0% |
| 2010 Q2 | 72.23 Million EUR | 0.0% |
| 2010 FY | 45.4 Million EUR | 612.52% |
| 2010 Q4 | 45.4 Million EUR | 0.0% |
| 2009 FY | 6.37 Million EUR | -82.37% |
| 2009 Q4 | 6.37 Million EUR | 0.0% |
| 2008 FY | 36.13 Million EUR | 38.02% |
| 2007 FY | 26.18 Million EUR | 10.92% |
| 2006 FY | 23.6 Million EUR | -7.11% |
| 2005 FY | 25.41 Million EUR | 52.8% |
| 2004 FY | 16.63 Million EUR | -68.97% |
| 2003 FY | 53.6 Million EUR | -70.86% |
| 2002 FY | 183.96 Million EUR | -20.99% |
| 2001 FY | 232.83 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Affluent Medical SA | 17.13 Million EUR | -142.693% |
| Bluelinea Société Anonyme | 3.61 Million EUR | -1048.877% |
| Carmat SA | 57.64 Million EUR | 27.869% |
| Diagnostic Medical Systems S.A. | 16.28 Million EUR | -155.345% |
| Euromedis Groupe | 10.01 Million EUR | -315.114% |
| Eurobio Scientific Société anonyme | 100.63 Million EUR | 58.678% |
| Ikonisys S.A. | 3.2 Million EUR | -1196.43% |
| Implanet S.A. | 6.15 Million EUR | -576.036% |
| Median Technologies SA | 23.01 Million EUR | -80.694% |
| SpineGuard SA | 3.08 Million EUR | -1247.865% |
| Theraclion SA | 1.95 Million EUR | -2031.657% |
| Euroapi S.A. | 225.5 Million EUR | 81.56% |
| Guerbet SA | 383.87 Million EUR | 89.167% |
| Koninklijke Philips N.V. | 7.68 Billion EUR | 99.459% |
| Sequana Medical NV | 16.78 Million EUR | -147.71% |